Cancer Research Aziza Shad  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, C.-P. H.
Right arrow Articles by Horwitz, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, C.-P. H.
Right arrow Articles by Horwitz, S. B.
[Cancer Research 60, 5171-5178, September 15, 2000]
© 2000 American Association for Cancer Research


Experimental Therapeutics

Taxol Mediates Serine Phosphorylation of the 66-kDa Shc Isoform1

Chia-Ping Huang Yang and Susan Band Horwitz2

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461

In the human lung carcinoma cell line A549, Taxol (20 nM) causes a decreased electrophoretic mobility of the 66-kDa Shc isoform (p66shc), beginning 4 h after drug exposure, and reaching a maximum at 9–18 h. No shift was observed for the 52- and 46-kDa isoforms of Shc. The electrophoretic mobility shift of p66shc caused by Taxol is not the result of tyrosine phosphorylation, and there is no indication of a Shc/Grb2 complex in Taxol-treated A549 cells. This modification is blocked by the serine/threonine protein phosphatase 2A. In vivo 32P-labeling and subsequent phosphoamino acid analysis of p66shc indicated that both the original and the shifted p66shc were predominantly serine phosphorylated. Cyanogen bromide digestion of p66shc produced a phosphorylated fragment with an apparent molecular weight of ~7.9 kDa from the untreated cells and two phosphorylated fragments, of ~7.9 and ~9.6 kDa, from the Taxol-treated cells. The domain of Taxol-induced serine phosphorylation is thought to be in the cyanogen bromide fragment containing residues 2–65. The Taxol-induced electrophoretic mobility shift of p66shc was inhibited by the protein synthesis inhibitor, cycloheximide, but not by the mitogen-activated and extracellular signal-regulated protein kinase kinase (MEK) inhibitor, PD98059. This mobility shift did not occur in Taxol-resistant A549-T12 cells treated with 20 nM Taxol. In addition to Taxol, other microtubule-interacting drugs caused a decreased electrophoretic mobility of p66shc. This Taxol-mediated serine phosphorylation seen in p66shc may result from a MEK-independent signaling pathway that is activated in cells that have a prolonged or abnormal mitotic phase of the cell cycle and may play a role in signaling events that lead to cell death.




This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
Y. Hu, X. Wang, L. Zeng, D.-Y. Cai, K. Sabapathy, S. P. Goff, E. J. Firpo, and B. Li
ERK Phosphorylates p66shcA on Ser36 and Subsequently Regulates p27kip1 Expression via the Akt-FOXO3a Pathway: Implication of p27kip1 in Cell Response to Oxidative Stress
Mol. Biol. Cell, August 1, 2005; 16(8): 3705 - 3718.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
W. W. Smith, D. D. Norton, M. Gorospe, H. Jiang, S. Nemoto, N. J. Holbrook, T. Finkel, and J. W. Kusiak
Phosphorylation of p66Shc and forkhead proteins mediates A{beta} toxicity
J. Cell Biol., April 25, 2005; 169(2): 331 - 339.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Pagnin, G. Fadini, R. de Toni, A. Tiengo, L. Calo, and A. Avogaro
Diabetes Induces p66shc Gene Expression in Human Peripheral Blood Mononuclear Cells: Relationship to Oxidative Stress
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1130 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. L. Tinley, D. A. Randall-Hlubek, R. M. Leal, E. M. Jackson, J. W. Cessac, J. C. Quada Jr., T. K. Hemscheidt, and S. L. Mooberry
Taccalonolides E and A: Plant-derived Steroids with Microtubule-stabilizing Activity
Cancer Res., June 15, 2003; 63(12): 3211 - 3220.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Lee, W. Yang, K.-H. Lan, S. Sellappan, K. Klos, G. Hortobagyi, M.-C. Hung, and D. Yu
Enhanced Sensitization to Taxol-induced Apoptosis by Herceptin Pretreatment in ErbB2-overexpressing Breast Cancer Cells
Cancer Res., October 15, 2002; 62(20): 5703 - 5710.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Faisal, M. El-Shemerly, D. Hess, and Y. Nagamine
Serine/Threonine Phosphorylation of ShcA. REGULATION OF PROTEIN-TYROSINE PHOSPHATASE-PEST BINDING AND INVOLVEMENT IN INSULIN SIGNALING
J. Biol. Chem., August 9, 2002; 277(33): 30144 - 30152.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Le, T. J. Connors, and A. C. Maroney
c-Jun N-terminal Kinase Specifically Phosphorylates p66ShcA at Serine 36 in Response to Ultraviolet Irradiation
J. Biol. Chem., December 14, 2001; 276(51): 48332 - 48336.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. M. McDaid and S. B. Horwitz
Selective Potentiation of Paclitaxel (Taxol)-Induced Cell Death by Mitogen-Activated Protein Kinase Kinase Inhibition in Human Cancer Cell Lines
Mol. Pharmacol., August 1, 2001; 60(2): 290 - 301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-i. Okano and A. K. Rustgi
Paclitaxel Induces Prolonged Activation of the Ras/MEK/ERK Pathway Independently of Activating the Programmed Cell Death Machinery
J. Biol. Chem., May 25, 2001; 276(22): 19555 - 19564.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.